elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34149681-7F04B2CB-9481-4EF0-8CDA-FECA82B13122
Q34149681-7F04B2CB-9481-4EF0-8CDA-FECA82B13122
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34149681-7F04B2CB-9481-4EF0-8CDA-FECA82B13122
Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility
P2860
Q34149681-7F04B2CB-9481-4EF0-8CDA-FECA82B13122
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34149681-7F04B2CB-9481-4EF0-8CDA-FECA82B13122
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dfc1f15bb0212c81cceb3d103c57238de1b2b730
P2860
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.